Actavis New Zealand
Title: Actavis New Zealand
Keywords: Actavis New Zealand
Description: Actavis New Zealand is committed to providing New Zealand pharmacists with long-term sustainable value across a broad product portfolio. is ranked 12006267 in the world (amongst the 40 million domains). A low-numbered rank means that this website gets lots of visitors. This site is relatively popular among users in the united states. It gets 50% of its traffic from the united states .This site is estimated to be worth $9,696. This site has a low Pagerank(0/10). It has 1 backlinks. has 43% seo score. Information

Website / Domain:
Website IP Address:
Domain DNS Server:,, Rank

Alexa Rank: 12006267
Google Page Rank: 0/10 (Google Pagerank Has Been Closed) Traffic & Earnings

Purchase/Sale Value: $9,696
Daily Revenue: $26
Monthly Revenue $796
Yearly Revenue: $9,696
Daily Unique Visitors 2,444
Monthly Unique Visitors: 73,320
Yearly Unique Visitors: 892,060 WebSite Httpheader

StatusCode 200
Date Mon, 01 Aug 2016 01:43:31 GMT
Server Microsoft-IIS/6.0
Cache-Control private
Content-Type text/html; charset=utf-8 Keywords accounting

Keyword Count Percentage
Actavis New Zealand 4 3.23% Traffic Sources Chart Similar Website

Domain Site Title New Wine New Zealand Shell New Zealand - New Zealand New Zealand | Zoetis New Zealand New Zealand in New Zealand New Zealand New Zealand NEW ZEALAND! New Zealand Actavis Epilepsi Alexa Rank History Chart aleax Html To Plain Text

Actavis New Zealand Actavis New Zealand Home About Us Senior Management Sales Team Local Message Contact Us Products OTC Medicine (without prescription) Rx Medicine Health Care Brands Beauty Brands Dermatology Brands Research and development Quality News Careers Actavis plc (NYSE: ACT) is focused on developing, manufacturing and commercializing high quality affordable generic and innovative branded pharmaceutical products for patients around the world. Actavis New Zealand is committed to providing pharmacists with long-term sustainable value across a broad product portfolio. This commitment is based on a partnership approach with pharmacists with value, choice, service & support central to the company’s offering. News 17 MAR 2015 / Other News Actavis Completes Allergan Acquisition 26 FEB 2015 / Other News Actavis Announces Intention to Adopt "Allergan" Corporate Name News Archive Truly Global Now we have the global resource to bring the best possible generic options to New Zealand. We have an industry leading global product portfolio of more than 750 molecules offered in more than 1,700 different combinations and dosage forms through our global operations, which includes all significant drug delivery technologies. Find more Prescription Medicines Wider Access for more Patients Actavis has played a key part in enabling many pharmaceuticals to be fully funded for the first time; such as the Ava low dose oral contraceptive and Tolterodine for OAB patients intolerant of oxybutynin. We ensure that more pharmaceuticals are made more readily available at a lower cost; such as the removal of the Special Authority for Lamotrigine, the funding of Tramadol and Sertraline and the significant price reduction on Venlafaxine. Find more ArrowCare Medicines that families can afford ArrowCare is our umbrella brand for non-prescription medicines. Generic medicines are now more popular as consumers realise that they can pay a lot less for the same active ingredient as the original brands. Find more NEW ProfalFinasteride 1mg Treatment for Male Pattern Hair Loss Find more Over The Counter Brands Our range does not stop at medicines but includes health, beauty and dermatology products as well: Crampeze Dermalab skincare products Find more Sitemap Disclaimer Privacy policy Actavis New Zealand Ltd, PO Box 128244, Remuera, Auckland 1541, New Zealand ? Tel: +64 9 630 4488 ? ? Actavis 2016 Whois

Domain Name: ACTAVIS.CO.NZ